Designed in the TED Talk style, In the Rheum sessions will feature the hottest topics and biggest scientific takeaways for rheumatology using a shorter, more casual approach during the 2019 ACR/ARP Annual Meeting…
Search results for: hospital
Baricitinib: Early vs. Late Treatment Outcomes in RA Patients
Recent research found that RA patients who began treatment with baricitinib experienced greater improvement from baseline than patients who began treatment with methotrexate…
Jinoos Yazdany, MD, MPH, Advances RISE Through the Registries and Health IT Committee
With her combined expertise in rheumatology and informatics, Dr. Yazdany is leading the ACR’s Registries and Health Information Technology Committee to create a national health IT infrastructure that advances rheumatology practice.
Secukinumab: The Real World Experience of PsA Patients
Secukinumab therapy proved safe and effective for psoriatic arthritis patients with multiple co-morbidities and long treatment histories, according to recent research…
RheumPAC Advocates for Department of Defense Arthritis Research Funding
The ACR’s nonpartisan political action committee is continuing to advocate for increased defense department funding for rheumatology research. Learn about RheumPAC’s efforts and how you can help.
RA Patients May Safely Stop Methotrexate in Tofacitinib Combination Therapy
RA patients who achieve low disease activity on tofacitinib and methotrexate combination therapy can safely cease methotrexate use, according to recent research…
Peripheral Arthritis & Recent Onset Axial SpA: 5-Year Results from the DESIR Cohort
An analysis of follow-up data from the DESIR cohort showed patients with recent onset axial spondyloarthritis who experienced peripheral arthritis had worse symptoms and quality of life long term. In the study, peripheral arthritis was also associated with negative HLAB27, non-smoking and the presence of other peripheral disease manifestations…
Subcutaneous CT-P13 Injection Evaluated for Safety & Efficacy of in RA Patients
Results from a one-year study suggest subcutaneous CT-P13, which is biosimilar to infliximab, is as safe and effective for RA patients as intravenous (IV) CT-P13 and IV infliximab…
An Interdisciplinary & Holistic Approach to Alleviating Pediatric Pain
Interdisciplinary collaboration is proving valuable to address bio-psycho-social pain management in pediatric patients at Children’s Hospital Los Angeles…
Ethics Forum: Beware Your Intellectual Conflicts of Interest
A senior rheumatologist with extensive experience in the management of systemic lupus erythematosus is asked to help draft clinical guidelines for the treatment of lupus nephritis. Neither she nor her family members receive grant funding nor does she consult with any pharmaceutical or biotechnology companies. She does have strong clinical opinions based on current evidence…
- « Previous Page
- 1
- …
- 124
- 125
- 126
- 127
- 128
- …
- 330
- Next Page »